Determination of galactosamine impurities in heparin samples by multivariate regression analysis of their (1)H NMR spectra.
Heparin, a widely used anticoagulant primarily extracted from animal sources, contains varying amounts of galactosamine impurities. Currently, the United States Pharmacopeia (USP) monograph for heparin purity specifies that the weight percent of galactosamine (%Gal) may not exceed 1%. In the present study, multivariate regression (MVR) analysis of (1)H NMR spectral data obtained from heparin samples was employed to build quantitative models for the prediction of %Gal. MVR analysis was conducted using four separate methods: multiple linear regression, ridge regression, partial least squares regression, and support vector regression (SVR). Genetic algorithms and stepwise selection methods were applied for variable selection. In each case, two separate prediction models were constructed: a global model based on dataset A which contained the full range (0-10%) of galactosamine in the samples and a local model based on the subset dataset B for which the galactosamine level (0-2%) spanned the 1% USP limit. All four regression methods performed equally well for dataset A with low prediction errors under optimal conditions, whereas SVR was clearly superior among the four methods for dataset B. The results from this study show that (1)H NMR spectroscopy, already a USP requirement for the screening of contaminants in heparin, may offer utility as a rapid method for quantitative determination of %Gal in heparin samples when used in conjunction with MVR approaches.
Zang
Qingda
Q
Department of Pharmacology, Robert Wood Johnson Medical School, University of Medicine & Dentistry of New Jersey, Piscataway, NJ 08854, USA.
Keire
David A
DA
Wood
Richard D
RD
Buhse
Lucinda F
LF
Moore
Christine M V
CM
Nasr
Moheb
M
Al-Hakim
Ali
A
Trehy
Michael L
ML
Welsh
William J
WJ
D000465:Algorithms; D000818:Animals; D000925:Anticoagulants / Q000737:chemistry*; D004340:Drug Contamination; D005688:Galactosamine / Q000032:analysis*; D006493:Heparin / Q000737:chemistry*; D016018:Least-Squares Analysis; D009682:Magnetic Resonance Spectroscopy / Q000191:economics / Q000379:methods*; D015999:Multivariate Analysis; D012044:Regression Analysis
D000925:Anticoagulants; D005688:Galactosamine; D006493:Heparin